Gender and comorbidity among individuals with opioid use disorders in the NESARC study

Addictive Behaviors

Volumn 34, Issue 6-7, 2009, Pages 498-504

  Grella, Christine E ^a   Karno, Mitchell P ^a   Warda, Umme S ^a   Niv, Noosha ^a   Moore, Alison A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gender differences; Heroin; NESARC; Opioids; Psychiatric comorbidity

Indexed keywords

OPIATE;

ADULT; ANXIETY DISORDER; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LIFESPAN; LOGISTIC REGRESSION ANALYSIS; MALE; MENTAL DISEASE; MOOD DISORDER; OPIATE ADDICTION; PARANOID PSYCHOSIS; PSYCHOPATHY; SEX DIFFERENCE; SUBSTANCE ABUSE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY DISORDERS; DIAGNOSIS, DUAL (PSYCHIATRY); EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; MOOD DISORDERS; OPIOID-RELATED DISORDERS; PERSONALITY DISORDERS; SEX DISTRIBUTION; SEX FACTORS; YOUNG ADULT;

EID: 65549165047     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2009.01.002     Document Type: Article

References (59)

1. Ahmadi J., Majdi B., Mahdavi S., and Mohagheghzadeh M. Mood disorders in opioid-dependent patients. Journal of Affective Disorders 82 1 (2004) 139-142
2. Anthony J., Neumark Y., and Van Etten M. Do I do what I say?: A perspective on self-report methods in drug dependence epidemiology. In: Stone A., Turkkan J., and Bachrach C. (Eds). The science of self-report: Implications for research and practice (2000), Lawrence Earlbaum Associates, Hillsdale, NJ 175-198
3. Blanco C., Alderson D., Ogburn E., Grant B.F., Nunes E.V., Hatzenbuehler M.L., et al. Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug and Alcohol Dependence 90 (2007) 252-260
4. Borges G., Walters E.E., and Kessler R.C. Associations of substance use, abuse, and dependence with subsequent suicidal behaviour. American Journal of Epidemiology 151 (2000) 781-789
5. Brands B., Blake J., Sproule B., Gourlay D., and Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug and Alcohol Dependence 73 (2004) 199-207
6. Brooner R.K., King V.L., Kidorf M., Schmidt C.W., and Bigelow G.E. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Archives of General Psychiatry 54 1 (1997) 71-80
7. Cacciola J.S., Alterman A.I., Rutherford M.J., McKay J.R., and Mulvaney F.D. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug and Alcohol Dependence 61 (2001) 271-280
8. Callaly T., Trauer T., Munro L., and Whelan G. Prevalence of psychiatric disorder in a methadone maintenance population. Australian and New Zealand Journal of Psychiatry 35 (2001) 601-605
9. Calsyn D.A., Fleming C., Wells E.A., and Saxon A.J. Personality disorder subtypes among opiate addicts in methadone maintenance. Psychology of Addictive Behaviors 10 1 (1996) 3-8
10. Chatham L.R., Hiller M.L., Rowan-Szal G.A., Joe G.W., and Simpson D.D. Gender differences at admission and follow-up in a sample of methadone maintenance clients. Substance Use & Misuse 34 8 (1999) 1137-1165
11. Cicero T.J., Inciardi J.A., and Munoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. Journal of Pain 6 10 (2005) 662-672
12. Coffin P.O., Tracy M., Bucciarelli A., Ompad D., Vlahov D., and Galea S. Identifying injection drug users at risk of nonfatal overdose. Academic Emergency Medicine 14 7 (2007) 616-623
13. Compton W.M., Cottler L.B., Jacobs J.L., Ben-Abdallah A., and Spitznagel E.D. The role of psychiatric disorders in predicting drug dependence treatment outcomes. American Journal of Psychiatry 160 5 (2003) 890-895
14. Compton W.M., and Volkow N.D. Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug and Alcohol Dependence 81 (2006) 103-107
15. Conway K.P., Compton W., Stinson F.S., and Grant B.F. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 67 2 (2006) 247-257
16. Darke S., Hall W.D., and Swift W. Prevalence, symptoms and correlates of antisocial personality disorder among methadone maintenance clients. Drug and Alcohol Dependence 34 3 (1994) 253-257
17. Darke S., and Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug and Alcohol Dependence 48 (1997) 135-141
18. Darke S., Ross J., and Teesson M. The Australian treatment outcome study (ATOS): What have we learnt about treatment for heroin dependence?. Drug and Alcohol Review 26 (2007) 49-54
19. Darke S., Swift W., and Hall W. Prevalence, severity and correlates of psychological morbidity among methadone maintenance clients. Addiction 89 2 (1994) 211-217
20. Darke S., Williamson A., Ross J., and Teesson M. Reductions in heroin use are not associated with increases in other drug use: 2-year findings from the Australian treatment outcome study. Drug and Alcohol Dependence 84 2 (2006) 201-205
21. Darke S., Wodak A., Hall W., Heather N., and Ward J. Prevalence and predictors of psychopathology among opioid users. British Journal of Addiction 87 (1992) 771-776
22. Del Boca F.K., and Noll J.A. Truth or consequences: The validity of self-report data in health services research on addictions. Addiction 95 (2000) S347-S360
23. Fischer B., and Rehm J. Illicit opioid use in the 21st century: Witnessing a paradigm shift?. Addiction 102 4 (2007) 499-501
24. Fischer B., Rehm J., Brissette S., Brochu S., Bruneau J., el-Guebaly N., et al. Illicit opioid use in Canada: Comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN Study). Journal of Urban Health 82 2 (2005) 250-266
25. Fischer B., Rehm J., Patra J., and Firestone-Cruz M. Changes in illicit opioid use across Canada. Canadian Medical Association Journal 175 11 (2006) 1385-1387
26. Grant B.F., Dawson D.A., Stinson F.S., Chou P.S., Kay W., and Pickering R. The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): Reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug and Alcohol Dependence 71 (2003) 7-16
27. Grant B.F., and Hasin D.S. The Alcohol Use Disorders and Associated Disabilities Interview Schedule (1991), National Institute of Alcohol Abuse and Alcoholism, Rockville, MD
28. Grant B.F., Hasin D.S., Stinson F.S., Dawson D.A., Chou S.P., Ruan W.J., et al. Prevalence, correlates, and disability of personality disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 65 (2004) 948-958
29. Grant B.F., Stinson F.S., Dawson D.A., Chou P., Dufour M.C., Compton W., et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry 61 8 (2004) 807-816
30. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., and Ruan W.J. Co-occurrence of DSM-IV personality disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Comprehensive Psychiatry 46 1 (2005) 1-5
31. Grant B.F., and Weissman M.M. Gender and the prevalence of psychiatric disorders. In: Narrow W.E., First M.B., Sirovatk M., and Regier D.A. (Eds). Age and gender considerations in psychiatric diagnosis: A research agenda for DSM-V (2007), American Psychiatric Association, Arlington, VA 31-45
32. Grau L.E., Dasgupta N., Harvey A.P., Irwin K., Givens A., Kinzly M.L., et al. Illicit use of opioids: Is OxyContin® a "gateway drug"?. American Journal on Addictions 16 (2007) 166-173
33. Havard A., Teesson M., Darke S., and Ross J. Depression among heroin users: 12-month outcomes from the Australian treatment outcome study. Journal of Substance Abuse Treatment 30 (2006) 355-362
34. Hser Y.-I., Evans E., Huang D., Brecht M.-L., and Li L. Comparing the dynamic course of heroin, cocaine, and methamphetamine use over 10 years. Addictive Behaviors 33 (2008) 1581-1589
35. Huang B., Dawson D.A., Stinson F.S., Hasin D.S., Ruan W.J., Saha T.D., et al. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry 67 (2006) 1062-1073
36. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., and Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity survey replication. Archives of General Psychiatry 62 (2005) 593-602
37. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Study. Archives of General Psychiatry 51 1 (1994) 8-19
38. Kessler R.C., Nelson C.B., McGonagle K.A., Edlund M.J., Frank R.G., and Leaf P.J. The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry 66 (1996) 17-31
39. Luthar S.S., Cushing G., and Rounsaville B.J. Gender differences among opioid abusers: Pathways to disorder and profiles of psychopathology. Drug and Alcohol Dependence 43 3 (1996) 179-190
40. Mason B.J., Kocsis J.H., Melia D., Khuri E.T., Sweeney J., Wells A., et al. Psychiatric comorbidity in methadone maintained patients. Journal of Addictive Diseases 17 3 (1998) 75-89
41. McCabe S.E., Cranford J.A., and West B.T. Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: Results from two national surveys. Addictive Behaviors 33 (2008) 1297-1305
42. Mills K.L., Teesson M., Ross J., and Darke S. The impact of post-traumatic stress disorder on treatment outcomes for heroin dependence. Addiction 102 (2007) 447-454
43. Narrow W.E., Rae D.S., Robins L.N., and Regier D.A. Revised prevalence estimates of mental disorders in the United States: Using a clinical significance criterion to reconcile 2 surveys' estimates. Archives of General Psychiatry 59 (2002) 115-123
44. Paulozzi L.J., Budnitz D.S., and Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiology and Drug Safety 15 9 (2006) 618-627
45. Peles E., Schreiber S., Naumovskya Y., and Adelson M. Depression in methadone maintenance treatment patients: Rate and risk factors. Journal of Affective Disorders 99 (2007) 213-220
46. Research Triangle Institute. Software for Survey Data Analysis (SUDAAN). Version 9.0. Research Triangle Institute, Research Triangle Park, NC (2005)
47. Rosenblum A., Parrino M., Schnoll S.H., Fong C., Maxwell C., Cleland C.M., et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug and Alcohol Dependence 90 1 (2007) 64-71
48. Ross J., Teesson M., Darke S., Lynskey M., Ali R., Ritter A., et al. The characteristics of heroin users entering treatment: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Review 24 (2005) 411-418
49. Rounsaville B.J., Kosten T.R., Weissman M.M., and Kleber H.D. Prognostic significance of psychopathology in treated opiate addicts: A 2.5-year follow-up study. Archives of General Psychiatry 43 8 (1986) 739-745
50. Rounsaville B.J., Weissman M.M., Kleber H., and Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Archives of General Psychiatry 39 2 (1982) 161-166
51. Rutherford M.J., Cacciola J.S., Alterman A.I., and Cook T.G. Social competence in opiate-addicted individuals: Gender differences, relationship to psychiatric diagnoses, and treatment response. Addictive Behaviors 22 3 (1997) 419-425
52. Stinson F.S., Dawson D.A., Patricia Chou S., Smith S., Goldstein R.B., and June Ruan W. The epidemiology of DSM-IV specific phobia in the USA: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychological Medicine 37 7 (2007) 1047-1059
53. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. The NSDUH Report: Nonmedical use of prescription pain relievers. Rockville, MD (2004, May 21). http://www.oas.samhsa.gov/2k4/pain/pain.cfm Retrieved July 23, 2007 from http://www.oas.samhsa.gov/2k4/pain/pain.cfm
54. Sullivan M.D., Edlund M.J., Steffick D., and Unützer J. Regular use of prescribed opioids: Association with common psychiatric disorders. Pain 119 1-3 (2005) 95-103
55. Teesson M., Ross J., Darke S., Lynskey M., Ali R., Ritter A., et al. One year outcomes for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Dependence 83 2 (2006) 174-180
56. Tetrault J.M., Desai R.A., Becker W.C., Fiellin D.A., Concato J., and Sullivan L.E. Gender and non-medical use of prescription opioids: Results from a national US survey. Addiction 103 2 (2007) 258-268
57. Turner R.J. The pursuit of socially modifiable contingencies in mental health. Journal of Health and Social Behavior 44 (2003) 1-17
58. United Nations, Office of Drugs and Crime. World drug report (2007). http://www.unodc.org/unodc/en/data Retrieved December 14, 2007 from http://www.unodc.org/unodc/en/data-and-analysis/WDR-2007.html
59. Vesga-López O., Schneier F.R., Wang S., Heimberg R.G., Liu S.M., Hasin D.S., et al. Gender Differences in Generalized Anxiety Disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Journal of Clinical Psychiatry 69 (2008) 1606-1616